
Venture capital due diligence is different from every other form of investment research. You are not validating a track record — you are validating a hypothesis about the future. Expert networks are how the best VC firms stress-test those hypotheses before they write the cheque.
Venture capital firms use expert networks to validate product-market fit assumptions, assess founding team credibility, understand competitive dynamics in nascent markets, and evaluate regulatory trajectories that will affect the startup's growth path. The goal is not to confirm what the founder has told you — it is to find the people who can tell you what the founder does not know, or has not told you.
Market validation: Potential customers and buyers who can confirm whether the problem the startup is solving is real, acute, and worth paying to fix.
Founder and team assessment: Former colleagues, co-founders, and people who have worked alongside the founding team in previous roles.
Competitive landscape: Practitioners in adjacent sectors who understand which competing solutions exist, how they are positioned, and where the startup's differentiation is real versus claimed.
Regulatory trajectory: Former regulators, legal practitioners, and policy specialists who can assess how the regulatory environment is likely to evolve for the startup's business model.
In PE, you are typically validating an existing business with a track record. The question is whether the track record is sustainable and the thesis is sound. In VC, you are evaluating a hypothesis about a market that may not yet exist at scale. The expert population is therefore different. You need experts who are close to the problem domain, not necessarily experts in the company itself.
For a Series A investment in a healthcare AI company, the most valuable experts are not former executives of the target — they are hospital procurement officers who can tell you whether the buying committee would actually adopt this product, clinical informatics specialists who understand what the workflow integration challenges really are, and former digital health founders who have navigated the same regulatory path.
A venture capital fund was evaluating a seed-stage B2B SaaS company targeting mid-market manufacturers. The founding team's pitch showed strong pilot customer feedback and a compelling unit economics model. Expert calls with three procurement directors at comparable manufacturing companies revealed that the workflow the product was automating was already handled by a module within the ERP systems most mid-market manufacturers were rolling out. The total addressable market was significantly smaller than the founding team's model assumed. The fund renegotiated the terms and reduced its cheque size. The insight came from a single 45-minute expert call with a procurement director who had seen the same pitch from two competitors.
The brief for an early-stage expert call is fundamentally different from a buyout due diligence brief. You are not asking experts to assess a specific company — in many cases, the company is too early-stage to be known. You are asking them to assess the market, the problem, and the plausibility of the solution approach.
The most productive early-stage expert calls are structured around three questions: Is this problem real and acute enough to drive purchasing decisions? Is the approach this company is taking technically and commercially feasible? What would success look like in two to three years, and what would need to be true to get there?
Talking only to enthusiasts and early adopters rather than mainstream buyers who represent the real market. Not calling enough experts who are likely to be sceptical — the most valuable call is often with the practitioner who thinks the startup's approach will not work. Using expert networks only at the initial diligence stage and not refreshing primary intelligence at each subsequent funding round. Selecting experts based on seniority rather than proximity to the specific buying decision or workflow the startup is targeting.
Can expert networks help with pre-seed or seed-stage due diligence? Yes, though the brief structure is different. At pre-seed, the focus is on market and problem validation rather than company-specific assessment. Nextyn regularly supports VC firms at seed stage by providing access to practitioners who can validate the problem hypothesis independently of the founding team's pitch.
How many expert calls are typically needed for VC due diligence? For a Series A or Series B investment, five to ten calls across different practitioner types typically provides adequate coverage. For earlier stages, three to five calls focused specifically on market and problem validation can be sufficient to make a go or no-go decision.
Can Nextyn help VC firms evaluating startups in emerging markets? Particularly well. Early-stage startups in APAC, South Asia, and MEA often operate in markets where secondary research is sparse and where the most relevant practitioner perspectives are only accessible through local expert networks. Nextyn's embedded regional teams in Mumbai, Singapore, and Jakarta are specifically structured to support this type of research.
Nextyn has supported venture capital firms across Asia, the Middle East, and globally with expert network services for deal-stage diligence, market validation, and portfolio company monitoring. Our engagement model is flexible and designed to match the varied cadence of VC research — from rapid pre-investment calls to ongoing portfolio support. If you are building your VC firm's primary research capability, we welcome the conversation.